
"Health wise I am feeling great. I am a big supporter of trials - it allows new treatments and drugs to be brought in.”
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
This study is looking at giving triptorelin (Decapeptyl) every 6 months instead of every 3 months to treat prostate cancer.
Doctors can treat prostate cancer with surgery, radiotherapy or hormone therapy. This study is looking at men who are having hormone therapy.
Doctors can use the hormone therapy drugs goserelin (Zoladex), leuprorelin (Prostap) and triptorelin (Decapeptyl SR). You usually have these every 3 months. The researchers have developed a new type of triptorelin that you have every 6 months. They want to compare having triptorelin every 6 months with having other hormone therapy drugs every 3 months.
The aims of this trial are to find out
You may be able to enter this study if you
You cannot enter this study if you
This is a phase 4 study. It will recruit 168 men in the UK. This is a randomised study. The men taking part are put into treatment groups by a computer. Neither you nor your doctor will be able to decide which group you are in.
The men in group 1 will continue to have their hormone therapy injections every 3 months. The men in group 2 will have their triptorelin hormone injection every 6 months.
The trial team will ask you to fill out 2 questionnaires before you start treatment and at 6 and 12 months during your treatment. The questionnaire will ask about side effects, how you’ve been feeling and how satisfied you are with your current prostate cancer medication. This is called a quality of life study.
All study visits take place at your general practitioners (GP). How many visits you have will depend on which group are in.
Before taking part in this study everyone will see the doctor for a physical examination and blood tests.
During treatment you see the doctor every 3 months if you are in group 1 and every 6 months if you are in group 2. At 6 and 12 months you have a physical examination and blood tests.
After treatment your doctor will talk to you about which treatment is best for you.
The most common side effects of goserelin, leuprorelin and triptorelin are
We have more information on goserelin, leuprorelin and triptorelin in our cancer drugs section.
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Timothy Hall
Ipsen
Freephone 0808 800 4040
"Health wise I am feeling great. I am a big supporter of trials - it allows new treatments and drugs to be brought in.”